DermaPhage | biocogent-llc

Paul and Rebecca discuss
Adapting a 4-Billion-Year-Old Predator to Naturally Counter a Complicated Member of the Skin Microbiome
presented at the 2023 IFSCC Conference

DermaPhage® products are infused with a unique combination of at least three bacteriophages (or simply phages) that are uniquely targeted to a specific bacterial member of the skin microbiome. Grounded in a discovery made more than a century ago, these phages have a phenomenal safety profile coupled with clinically proven efficacy. This technology offers exquisite specificity when seeking to modulate the levels of a particular constituent bacterium of the normal microbiota of the skin, which can ameliorate a variety of different skin conditions.

DermaPhage® CA

Proprietary combination of three (3) unique bacteriophages targeted to the bacterium Cutibacterium acnes.

A superior bio-active ingredient for any anti-blemish regimen that targets the microbial culprit of blemish-prone skin: Cutibacterium acnes. DermaPhage CA diminishes both the bacterium’s intrinsic population size and corresponding biofilms present on the skin. C. acnes biofilms are a composite of sticky extracellular substances secreted from the bacteria that coalesce into a resilient matrix that impedes anti-microbial countermeasures. The disruption of these matrices exposes the anaerobic bacteria to atmospheric oxygen, diminishing their expansive growth. Additionally, a key inflammatory factor, interleukin-8 (IL-8) is reduced after DermaPhage CA application, reducing inflammatory damage incurred from C. acnes overgrowth.